Healios K.K.
Status: Publicly traded
Direct answer
Healios K.K. is publicly traded on JPX under the ticker 4593.T.
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced...
Can you invest in Healios K.K.?
Yes. Healios K.K. is publicly traded on JPX under the ticker 4593.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Healios K.K.
Detailed equity research is provided by MarketSnap.